Table 2. | Baseline characteristics |
| Variable | Level |
Placebo (n = 26) |
20 mg (n = 26) |
30 mg (n = 26) |
40 mg (n = 26) |
Total (n = 104) |
|---|---|---|---|---|---|---|
| Sex, N (%) | Male | 8 (30.8) | 8 (30.8) | 8 (30.8) | 8 (30.8) | 32 (30.8) |
| Female | 18 (69.2) | 18 (69.2) | 18 (69.2) | 18 (69.2) | 72 (69.2) | |
| Age, years | Mean (SD) | 24.62 (4.97) | 26.81 (6.52) | 25.62 (6.17) | 26.65 (6.28) | 25.92 (5.99) |
| Median | 24 | 25.5 | 23 | 24 | 24 | |
| Q1; Q3 | 21; 26.75 | 22; 30 | 21; 29 | 22.25; 30 | 21; 29 | |
| Min | 18 | 18 | 18 | 18 | 18 | |
| Max | 38 | 39 | 39 | 39 | 39 | |
| Smoking, N (%) | No | 24 (92.3) | 24 (92.3) | 22 (84.6) | 24 (92.3) | 94 (90.4) |
| Yes | 2 (7.7) | 2 (7.7) | 4 (15.4) | 2 (7.7) | 10 (9.6) |
N = number; Q1 = first quartile; Q3 = third quartile; SD = standard deviation. |
.png)
.png)
.png)
.png)